Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro

Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus. Here we reported the in vitro activity of azvudine against HIV-1 and HIV-2 when used alone or in combination with other antiretroviral drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui-Rui, Yang, Qing-Hua, Luo, Rong-Hua, Peng, You-Mei, Dai, Shao-Xing, Zhang, Xing-Jie, Chen, Huan, Cui, Xue-Qing, Liu, Ya-Juan, Huang, Jing-Fei, Chang, Jun-Biao, Zheng, Yong-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140803/
https://www.ncbi.nlm.nih.gov/pubmed/25144636
http://dx.doi.org/10.1371/journal.pone.0105617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140803/
https://www.ncbi.nlm.nih.gov/pubmed/25144636
http://dx.doi.org/10.1371/journal.pone.0105617

Ejemplares similares